renal cell carcinoma
推荐文章

释义
肾细胞癌;
权威例句
Renal-cell carcinoma.Renal-cell carcinoma.
Renal cell carcinoma
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.
Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma.
Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns
Sunitinib in patients with metastatic renal cell carcinoma.
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma: Commentary
Re: Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up
Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma.
EAU Guidelines on Renal Cell Carcinoma: The 2010 Update
1. This large renal cell carcinoma shows cyst formation and foci of hemorrhage and necrosis.
本例肾细胞癌瘤体巨大,伴发小囊肿形成、局灶性出血和坏死。
youdao
2. Conclusion: in surgical treatment of renal cell carcinoma, CT of renal cell carcinoma had guide-role in chosen operation and scope of operation.
结论:在肾癌外科治疗中,CT检查对于手术方式选择和确定手术范围有一定的指导作用。
youdao
3. Sorafenib is currently approved in the United States and other countries for treatment of advanced renal cell carcinoma.
当前索拉非尼在美国和其他国家被批准用来治疗晚期肾细胞癌。
youdao
4. Objective: to study the genesis and influential factors of multifocal renal cell carcinoma for the nephron sparing surgery.
目的:探讨多中心肾癌的发生机制及影响因素,为肾癌肾部分切除术寻找依据。
youdao
5. Background: Metastases of renal cell carcinoma (RCC) to the thyroid gland are uncommon.
背景:肾细胞癌发生甲状腺转移并不常见。
youdao
6. Objective: to establish orthotopic mouse models of human renal cell carcinoma and to separate metastatic or non-metastatic renal cell carcinoma (RCC) from the same source.
目的:建立原位移植裸鼠模型,筛选同一标本来源的转移性和非转移性肾细胞癌(RCC)。
youdao
7. According to these, this tumor can be differentiated from granular renal cell carcinoma, mixed renal cell carcinoma and chromophobe renal cell carcinoma.
据此,可与颗粒型肾细胞癌、混合型肾细胞癌及肾嫌色细胞癌鉴别。
youdao
8. PFS, rather than overall survival (OS), was accepted by regulatory authorities in the United States and Europe as the endpoint for approval of bevacizumab for the renal cell carcinoma indication.
欧美权威机构接受PFS作为观察终点,而非总生存期(OS),肾细胞癌作为贝伐单抗的适应症范围。
youdao
9. Purpose:To study the diagnosis and treatment of renal cell carcinoma with vena cava involvement.
目的:提高肾细胞癌伴静脉癌栓的诊治效果。
youdao
10. Here is a renal cell carcinoma that on sectioning is mainly cystic with extensive hemorrhage.
这是肾细胞癌的切面显示了肾胞囊扩张、出血。
youdao
11. Here is a renal cell carcinoma that on sectioning is mainly cystic with extensive hemorrhage.
肾细胞癌,切面是广泛出血造成的囊肿。
youdao
12. To investigate the utility of this method in assessing renal cancer risk, the researchers studied lymphocytes from 193 patients with confirmed renal cell carcinoma and a like number of controls.
为了研究这种方法在评估患肾癌风险中的应用,研究人员研究了193名确证患有肾细胞癌的患者的淋巴细胞以及相似数目的对照。
youdao
13. Objective To improve the diagnosis and treatment of renal cell carcinoma in adolescents.
目的提高青少年肾细胞癌的诊断和治疗水平。
youdao
14. Renal cell carcinoma (RCC) is the most common cancer of kidney in China.
肾细胞癌是我国泌尿生殖系统最常见的肿瘤之一。
youdao
15. Observed the expression of CD2AP in multilocular cystic renal cell carcinoma and its relationship with clinic pathologic feature.
观察CD 2ap在囊性肾透明细胞癌中的表达及其与临床病理特征的关系。
youdao
16. Conclusion: Chemotherapy with single drug is not a good treatment for renal cell carcinoma.
结论:单一药物的化疗不是肾脏肿瘤治疗的理想方案。
youdao
17. Objective To explore expression of CD2-associated protein (CD2AP) in multilocular cystic renal cell carcinoma and its relationship with clinic pathologic feature.
目的探讨CD 2相关蛋白(CD2AP)在囊性肾透明细胞癌中的表达及其与临床病理特征的关系。
youdao
18. However, a few cases, renal cell carcinoma will also contain adipose tissue, resulting in misdiagnosis.
但少数情况下,肾细胞癌组织中也会因含有脂肪组织,造成误诊。
youdao
19. Objective: to study the clinicopathologic features of sarcomatoid renal cell carcinoma (SRCC).
目的:观察肉瘤样肾细胞癌(SRCC)的临床病理特征。
youdao
20. Objective:To determine the prognostic value of DNA ploidy and nuclear morphometry, and its relations to nuclear grading in renal cell carcinoma.
目的:探讨图像细胞术测定肾细胞癌DNA倍体和核形态参数在预后判断上的价值及其与病变分级的关系。
youdao
21. Objective To study the expression of thrombomodulin (TM) in renal pelvic transitional cell carcinoma and in renal cell carcinoma.
目的研究血栓调节蛋白(TM)在肾盂移行细胞癌及肾细胞癌中的表达及临床意义。
youdao
22. Lung metastases are most common, followed by breast cancer, renal cell carcinoma, melanoma and lymphoma.
肺转移瘤是最常见的,其次乳腺癌、肾癌、黑色素瘤和淋巴瘤。
youdao
23. Objective: To study the diagnosis and treatment of renal cell carcinoma.
目的:探讨肾细胞癌的诊断及手术治疗。
youdao
24. Objective: To evaluate multiple spiral ct (MSCT) in the diagnosis of early renal cell carcinoma (RCC).
目的:评价多层螺旋CT (MSCT)多期扫描在早期肾细胞癌(RCC)诊断中的价值。
youdao
25. Result: 50 cystic renal cell carcinoma patients confirmed by pathology after operations have certain features in the performances of two-dimensional acoustic image and color Doppler ultrasonic.
结果:50例手术后经病理证实的囊性肾癌患者其二维声像图表现及彩色多普勒表现具有一定的特征。
youdao
26. Objective: To improve the image diagnosis of cystic renal cell carcinoma.
目的:提高对囊性肾癌的影像学诊断水平。
youdao
27. Objective: To discuss the treatment for incidental renal cell carcinoma.
目的:探讨偶发性肾细胞癌的治疗方法。
youdao
28. Purpose: To improve CT diagnosis and pathologic knowledge of renal cell carcinoma.
目的:提高对肾细胞癌的CT诊断和病理认识。
youdao
29. Objective: To study the diagnosis and treatment of cystic renal cell carcinoma.
目的:探讨囊性肾细胞癌的诊断和治疗。
youdao
30. Objective: To study the diagnosis and treatment of cystic renal cell carcinoma.
目的:探讨囊性肾细胞癌的诊断和治疗。
youdao
renal cell carcinoma




